{{Rsnum
|rsid=805305
|Gene=DDAH2
|Chromosome=6
|position=31729610
|Orientation=minus
|GMAF=0.4711
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=DDAH2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 7.7 | 47.7 | 44.6
| HCB | 13.3 | 55.6 | 31.1
| JPT | 20.5 | 52.3 | 27.3
| YRI | 76.3 | 20.3 | 3.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 13.3 | 55.6 | 31.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19250061
|Title=Common genetic variation in DDAH2 is associated with intracerebral hemorrhage in Chinese population: a multicenter case-control study in China.
}}

{{PMID Auto
|PMID=19666123
|Title=Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension
}}

{{PMID Auto
|PMID=22428028
|Title=Pilot Study of the Association of the DDAH2 −449G Polymorphism with Asymmetric Dimethylarginine and Hemodynamic Shock in Pediatric Sepsis
|OA=1
}}

{{PMID Auto
|PMID=22558392
|Title=A Functional Variant of the Dimethylarginine Dimethylaminohydrolase-2 Gene Is Associated with Insulin Sensitivity
|OA=1
}}

{{PMID|20936901}} Assessment of serum levels of asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine in coronary artery disease.

{{PMID Auto
|PMID=22923027
|Title=Association study of dimethylarginine dimethylaminohydrolase 2 gene polymorphisms and coronary heart disease.
}}

{{PMID Auto
|PMID=23723249
|Title=GWAS3D: Detecting human regulatory variants by integrative analysis of genome-wide associations, chromosome interactions and histone modifications.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}